Wnt-targeted hair loss treatment

Mergers & Acquisitions Mubadala, Goldman Sachs to invest $700 mn in Kakao Mobility

United Arab Emirates’ sovereign wealth fund Mubadala Investment Co. and Goldman Sachs are set to invest a combined $700 million in Kakao Mobil...

Real estate Mirae Asset to be named Korea Post’s core real estate fund operator

Mirae Asset Global Investments Co. is set to manage the mandate of more than 600 billion won ($416.8 million) in core real estate fund investment by...

Alternative investments Meritz backs half of ex-manager’s $210 mn hedge fund

Meritz Financial Group Inc., one of South Korea’s most aggressive alternative asset managers, has committed 150 billion won ($105 million) to ...

Korean stock market NPS pours $3.9 bn to buttress Korean stock market

South Korea’s National Pension Service, the country’s largest institutional investor, has come to the rescue of the domestic stock marke...

Automobiles Kia to build North America-targeted electric pickup model

Kia Corp., South Korea’s second-largest carmaker, will build an electric pickup model tailored for North America to enter the world’s la...

Entertainment Kakao Entertainment sheds loss-making units, revives IPO prospects

Kakao Entertainment Corp. has been divesting unprofitable music labels and digital content platforms, which it has gobbled up over the past few year...

Pension funds Global assets drive Korean teachers' fund to 11.1% return in 2024

The Korean Teachers’ Credit Union (KTCU) achieved an 11.1% return on investments in 2024, with overseas portfolios in stocks, infrastructure a...

Corporate strategy Hyundai chief Chung Euisun targets software-led car dominance by 2028

Hyundai Motor Group Chairman Chung Euisun has set an ambitious target to outpace Tesla Inc. in software-defined vehicle (SDV) technology by 2028, un...

Leadership & Management Samsung in 'do or die' situation'; Lee sounds crisis alarm

Samsung Electronics Co. Chairman Lee Jae-yong has warned the company's executives that the South Korean tech giant has lost its characteristic "rele...

Stocks China stock funds outperform US funds in South Korea

Chinese stocks are attracting South Korean investors looking beyond Wall Street amid the downturn in US Big Tech stocks.South Korea’s equity f...

Pension funds South Korea’s pension fund NPS risks massive loss from Homeplus fiasco

South Korea’s National Pension Service (NPS), the nation’s biggest institutional investor, could lose more than 1 trillion won ($692 mil...

Foreign exchange South Korea’s forex reserves dip to nearly 5-year low in February

South Korea’s foreign exchange reserves diminished to the lowest level in nearly five years last month, largely due to the expanded forex swap...

Markets Mirae Asset launches world’s 1st passive target-date ETF

Mirae Asset Global Investments Co. is set to introduce the world’s first passive target-date exchange-traded fund (ETF) this month to attract ...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Corporate bonds One-third of Korean petrochem bonds incur valuation losses

South Korean institutional investors, including banks, insurers and securities companies, have yet to fully benefit from recent declines in bond yie...

Private equity EQT targets healthcare, technology, business service providers in Korea

EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...

Real estate PAG raises $4 bn for opportunistic Asia real estate fund

PAG, an Asia Pacific-focused alternative investment firm, on Friday announced the final close of its 10th opportunistic real estate fund at $4 billi...

Corporate restructuring SK Ecoplant seeks to sell waste treatment business for $1.4 billion

SK Ecoplant Co., a South Korean construction engineering and waste management company under SK Group, is seeking to dispose of its waste treatment b...

Leadership & Management Small firms emerge as prime targets of management disputes in Korea

Small and medium-sized enterprises (SMEs) accounted for the majority of disputes over corporate management control in South Korea last year, with th...

Mergers & Acquisitions LG Chem embarks on sale of dermal filler business worth $343 million

LG Chem Ltd., the world’s fourth-largest chemicals producer that is fostering vaccine and new drug development as new growth drivers, has kick...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Bio & Pharma Partners Investment, GordonMD eye $150 mn biotech fund launch

South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...

Earnings SK Hynix surpasses Samsung with record-high profit in Q4

SK Hynix Inc., the top supplier of high-bandwidth memory (HBM) chips to Nvidia Corp., on Thursday reported its highest-ever quarterly profit of 8.08...

Aerospace & Defense Hanwha Aerospace nears $276 million K9 howitzer deal with Vietnam

South Korea’s Hanwha Aerospace Co. is close to signing a 400 billion won ($276 million) deal to export as many as 30 units of the K9 Thunder s...

Earnings LG Energy logs 1st quarterly loss in over 3 years, outlook remains gloomy

LG Energy Solution Ltd. reported its first quarterly loss in more than three years on Thursday, adding to concerns that the world’s third-larg...

Automobiles Hyundai, Kia sell 7.23 mn units together in 2024, eye more sales in 2025

Hyundai Motor Co. and its sibling Kia Corp. have set a target to sell a combined 7.39 million units around the globe this year with greater focus on...

Bio & Pharma Yuhan’s lung cancer drug gets OK in Europe

Leclaza (ingredient: lazertinib), a new lung cancer treatment developed by South Korea’s Yuhan Corp. secured approval from the European Commis...

Central bank S.Korea’s c.bank chief sees limited impact of political turmoil on economy

South Korea’s central bank chief said on Wednesday the impact of political turmoil caused by martial law on Asia’s fourth-largest econom...

Bio & Pharma Celltrion obtains approval of Steqeyma from FDA

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Bio & Pharma SK Pharmteco bags obesity treatment deal worth up to $1.4 bn

SK Pharmteco Co., a contract development and manufacturing organization (CDMO), has secured an obesity treatment order worth up to 2 trillion won ($...